Leachables & Peptide Stability: Science-Driven Risk Mitigation in Single-Use Drug Product Processing

Sarah brings over 25 years of biotech and biopharmaceutical experience and currently serves as Senior Modality Leader, shaping strategy and execution in APeC for next-generation therapeutics, including extracellular vesicles/exosomes and peptides. Her career spans both commercial and technical roles, blending rigorous scientific depth with sharp business acumen. A passionate advocate for innovation, she leads translational programs that aim to bring transformative therapies to patients faster. She holds an honours degree in Applied Biology and Biotechnology from RMIT University, Melbourne

Ram Sheth has over 8 years experience in the bioprocessing industry managing large CapEx projects from design concept through development, testing, installation, and commissioning. He has also supported in design engineering and process improvement initiatives to improve operations across different business units. In his current role, he works directly with internal and external stakeholders to develop solutiosn that advance Single-Use (SU) technology in Sterile FIltration and Aseptic Filling applications. Ram holds a B.S.E. in Biomedical Engineering from the University of Massachusetts Lowell, and is currently purusing an MBA in Health Sector Strategy and Management from Boston Univeristy's Questrom School of Business.